| Drugs with this side effect as MedDRA Preferred Term
			
			
	  	5-fluorocytosine
				
			APAs
				
			Anidulafungin
				
				
					Hypoglycaemia: 6.87% - 8% CAS 76095-16-4
				
			D-penicillamine
				
			FK463
				
				
					Hypoglycaemia: 4.66% - 6.93% Fe(III
				
			Humalog
				
			Insulin
				
				
					Hypoglycaemia: very common, 0.296% - 67% Hypoglycaemic episodeL-Dmp
				
			LY146032
				
			Lantus
				
				
					Hypoglycaemia: 25.5% - 33% Hypoglycemic reaction: 2.56% - 3.42% Hypoglycaemic episodeLeuprorelin
				
			Lisinopril
				
				
					Hypoglycaemia: very rare, postmarketing Hypoglycemic reactionLyxumia
				
			Meropenem anhydrous
				
			NTBC
				
			NovoLog
				
				
					Hypoglycaemia: postmarketing, 27% - 76% Hypoglycemic reactionHypoglycaemic episode: postmarketing Nuvocid
				
			Octreotide
				
				
					Hypoglycaemia: common, 0-2% PGE1
				
			SOM230
				
				
					Hypoglycaemia: 3.75% - 14.6% Saxagliptin
				
				
					HypoglycaemiaHypoglycemic reactionSignifor
				
				
					Hypoglycaemia: 3.75% - 14.6% Symlin
				
			acetazolamide
				
			alogliptin
				
			alosetron
				
			amphotericin B
				
			aripiprazole
				
				
					HypoglycaemiaHypoglycemic reactionarsenic
				
			arsenic trioxide
				
			aspirin
				
			atazanavir
				
			atorvastatin
				
			atovaquone
				
				
					Hypoglycaemia: 1% - 15.5% atropine
				
			avanafil
				
			axitinib
				
			betaxolol
				
				
					Hypoglycaemia: postmarketing bicalutamide
				
			bisoprolol
				
			bosentan
				
			bromocriptine
				
			bupropion
				
				
					Hypoglycaemia: postmarketing caffeine
				
			canagliflozin
				
			carteolol
				
			carvedilol
				
				
					Hypoglycaemia: 0.1% - 1.6% cefpodoxime
				
			celecoxib
				
			celiprolol
				
			cevimeline
				
			chlorpromazine
				
			chlorpropamide
				
			cidofovir
				
				
					HypoglycaemiaHypoglycemic reactionciprofloxacin
				
			citalopram
				
				
					Hypoglycaemia: postmarketing, rare clarithromycin
				
				
					Hypoglycaemia: postmarketing clopidogrel
				
				
					Hypoglycaemia: postmarketing colesevelam
				
				
					Hypoglycaemia: 3% - 3.45% conivaptan
				
			dalbavancin
				
			dapagliflozin
				
				
					HypoglycaemiaHypoglycemic reactiondarunavir
				
				
					Hypoglycaemia: 1.5% - 3.7% deprenyl
				
				
					HypoglycaemiaHypoglycemic reaction: rare dexmedetomidine
				
				
					Hypoglycaemia: postmarketing, common, 5% - 6% dextromethorphan
				
			diclofenac
				
			didanosine
				
				
					Hypoglycaemia: postmarketing disopyramide
				
			donepezil
				
				
					Hypoglycaemia: infrequent dorzolamide
				
			doxorubicin
				
			duloxetine
				
				
					Hypoglycaemia: infrequent, frequent entacapone
				
			epinephrine
				
			ertapenem
				
			ethacrynic acid
				
			ethionamide
				
			everolimus
				
			exenatide
				
				
					Hypoglycaemia: 0% - 43.5% felbamate
				
			fenofibrate
				
			fentanyl
				
			fluocinolone acetonide
				
			fluoxetine
				
			fluvoxamine
				
			formoterol
				
			frovatriptan
				
			gabapentin
				
				
					Hypoglycaemia: infrequent gadobenate dimeglumine
				
			gadolinium
				
			gadoversetamide
				
			gatifloxacin
				
				
					Hypoglycaemia: postmarketing glibenclamide
				
			gliclazide
				
				
					HypoglycaemiaHypoglycaemic episodeglimepiride
				
				
					HypoglycaemiaHypoglycemic reactionHypoglycaemic episodeglipizide
				
			glucose solution
				
			haloperidol
				
				
					Hypoglycaemia: very rare, postmarketing hydroxychloroquine
				
			ibuprofen
				
				
					Hypoglycaemia: 12% Hypoglycemic reactionicodextrin
				
				
					Hypoglycaemia: postmarketing imatinib
				
			indomethacin
				
			insulin detemir
				
				
					Hypoglycaemia: 0.8% - 1.4% Hypoglycaemic episodeiron sucrose
				
			isoxsuprine
				
			ivacaftor
				
			labetalol
				
			lamivudine
				
			lanreotide
				
			lansoprazole
				
			lenalidomide
				
			lercanidipine
				
			leuprorelin acetate
				
			levobunolol
				
			linagliptin
				
				
					HypoglycaemiaHypoglycemic reactionlinezolid
				
				
					Hypoglycaemia: postmarketing liraglutide
				
				
					Hypoglycaemia: postmarketing lomefloxacin
				
			lorcaserin
				
			losartan
				
			medroxyprogesterone acetate
				
			memantine
				
				
					Hypoglycaemia: postmarketing meropenem
				
			metformin
				
			methylphenidate
				
				
					Hypoglycaemia: postmarketing metoprolol
				
			mifepristone
				
			moxifloxacin
				
			mycophenolate mofetil
				
				
					Hypoglycaemia: 9.1% - 10.5% mycophenolic acid
				
			naproxen
				
			nateglinide
				
				
					Hypoglycaemia: common, 0.4% - 2.4% nefazodone
				
			nelarabine
				
			nelfinavir
				
			nesiritide
				
			nilotinib
				
			norfloxacin
				
				
					Hypoglycaemia: postmarketing ofloxacin
				
				
					Hypoglycaemia: postmarketing Hypoglycemic reactionolanzapine
				
				
					Hypoglycaemia: infrequent omeprazole
				
				
					Hypoglycaemia: postmarketing orlistat
				
				
					Hypoglycaemia: postmarketing, uncommon oxcarbazepine
				
			oxprenolol
				
			oxycodone
				
			paclitaxel
				
			paliperidone
				
				
					Hypoglycaemia: very rare, postmarketing paricalcitol
				
			paroxetine
				
			pentamidine
				
			pergolide
				
				
					Hypoglycaemia: infrequent perhexiline
				
			perphenazine
				
			pilocarpine
				
			pioglitazone
				
				
					Hypoglycaemia: 0% - 30.6% piroxicam
				
			pramipexole
				
			prednisolone phosphate
				
			pregabalin
				
				
					Hypoglycaemia: infrequent, 1% - 3% Hypoglycemic reaction: rare prochlorperazine
				
			propranolol
				
			quetiapine
				
				
					Hypoglycaemia: infrequent quinidine
				
			ramipril
				
				
					Hypoglycaemia: postmarketing ramiprilat
				
				
					Hypoglycaemia: postmarketing rapamycin
				
			repaglinide
				
			rifapentine
				
			rifaximin
				
			rimonabant
				
			risperidone
				
				
					Hypoglycaemia: postmarketing, rare rivastigmine
				
				
					Hypoglycaemia: infrequent ropinirole
				
				
					Hypoglycaemia: infrequent ropivacaine
				
			rosiglitazone
				
			salbutamol
				
			saquinavir
				
			sertraline
				
				
					Hypoglycaemia: postmarketing, rare Hypoglycemic reaction: rare sibutramine
				
			sildenafil
				
			sitagliptin
				
				
					Hypoglycaemia: postmarketing, common sitaxsentan
				
			sodium ferric gluconate
				
			streptozotocin
				
			sulfadiazine
				
			sulfamethoxazole
				
			sulfasalazine
				
			sumatriptan
				
			sunitinib
				
			tacrolimus
				
			telavancin
				
			telmisartan
				
				
					Hypoglycaemia: postmarketing, rare terbinafine
				
			testosterone
				
				
					Hypoglycaemia: postmarketing thalidomide
				
			thiothixene
				
			thyroxine
				
			tiagabine
				
				
					Hypoglycaemia: infrequent tigecycline
				
				
					Hypoglycaemia: postmarketing, common timolol
				
				
					Hypoglycaemia: postmarketing tolazamide
				
			tolbutamide
				
			tolvaptan
				
			topiramate
				
			tramadol
				
				
					Hypoglycaemia: postmarketing trifluoperazine
				
			trimethoprim
				
			trimethoprim-sulfamethoxazole
				
			v 1784
				
				
					Hypoglycaemia: postmarketing vandetanib
				
			varenicline
				
			venlafaxine
				
				
					Hypoglycaemia: rare, infrequent vildagliptin
				
				
					Hypoglycaemia: uncommon, common vinflunine
				
			voriconazole
				
				
					Hypoglycaemia: postmarketing, common zalcitabine
				
			zaleplon
				
				
					Hypoglycaemia: rare Hypoglycemic reaction: rare ziprasidone
				
				
					Hypoglycaemia: rare Hypoglycemic reaction: rare zonisamide
				
			 | Drugs with this indication |